Advanced Bionics wins TÜV approval for Integro CI cochlear implant platform

Advanced Bionics, a Sonova unit, secured TÜV clearance for its Integro CI next-generation cochlear implant platform in Europe. Launch begins in select European markets, targeting new cochlear implant candidates, existing recipients upgrading processors, and clinical fitting workflows. Platform adds AI-based sound processing, SoundFinder localization, broader Bluetooth streaming, direct compatibility with Phonak’s Roger On Sphere microphone. U.S. commercialization remains pending, with Integro CI still awaiting FDA clearance. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sonova Holding AG published the original content used to generate this news brief on October 14, 2026, and is solely responsible for the information contained therein. (C)